Telomere, telomerase and liver disease
Open Access
- 22 December 2017
- journal article
- editorial
- Published by Wiley in Liver International
- Vol. 38 (1) , 33-34
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Nonalcoholic Fatty Liver Disease and HIV InfectionSeminars in Liver Disease, 2012
- AZT as a telomerase inhibitorFrontiers in Oncology, 2012
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer developmentNature, 2011
- Constitutional telomerase mutations are genetic risk factors for cirrhosisHepatology, 2011
- Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease: Comparison with telomere-specific quantitative FISH and p21 immunohistochemistryPathology International, 2010
- A Spectrum of Severe Familial Liver Disorders Associate with Telomerase MutationsPLOS ONE, 2009
- Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and PredictorsClinical Infectious Diseases, 2008
- Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLDLiver International, 2005
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Identification of a specific telomere terminal transferase activity in tetrahymena extractsCell, 1985